@neohts, i believe in the potential of Taurx. But i have bought n sold GenB for so many rounds already. In fact last month i promptly reminded a few times here that the taurx news is just 24 mth result n not approval yet so dont get too carried away.
Bought at 4.50 as expected after a long wait. Next waiting price is 4.00. Sure can get cos spent another 1B trying to get another casino licence. Once got 4.00, ready for the coming AGM
Posted by AngTayKor > 14 minutes ago | Report Abuse
@neohts, i believe in the potential of Taurx. But i have bought n sold GenB for so many rounds already. In fact last month i promptly reminded a few times here that the taurx news is just 24 mth result n not approval yet so dont get too carried away. ------------------ Even it is not approved, can the company sells this drug to make profit ? The US is not a gentleman country, she will delay the final approval unless it is an US drug company. Please advise. Thank you.
If no approval, of course much harder to sell the drug. However, HMTM is now available at HK under paid compassionate program. Taurx now applying to expand this program to other China territories like Macau guangdong region.
Unless LKT willing to sell out his 21% stake to SWF n crystalise the usd2b investment (probable value then) into cash after UAE CA, else its just a paper profit not even reflected in accounting books (probably still recorded at cost price).
Abt USA FDA, I believe its easier for FDA to approve weak problematic drugs developed by American pharmas like Biogen / Eli, than to reject a good drug with no side effects (especially after Tofersen's approval has opened a precedence for HMTM to follow using the AA pathway).
AngTayKor, HMTM is now available at HK under paid compassionate program. Taurx now applying to expand this program to other China territories like Macau guangdong region.
Can TauRX selling in China and south east Asia even without approval from FDA ?
Just look at mci patient group. At 18 mths we are still able to reversal back upwards n performing above the initial start point scores. Lecanemab can only slowdown by 27% n still declining at 73% + brain bleeding + brain shrinkage. HMTM can stop the decline + reverse back upwards.
@neohts, if no FDA approval but secure EMA CA, I believe can eventually sell to most territories except USA. Countries can also choose to follow EMA's decision.
genting really hit the 4.44 to close the gap. might rebounding next week. and after the good news announce and good QR coming it should be able to rebound soon.
Genting operator cunning, purposesly press down to let shareholder throw and they collect back your cheap ticket. and give u dividend as sweet of memories.
4.38 soon ,u will see it , safe Buy in 4.28 - 4.38 , this level will consolidate , curent trend is downtrend , du beli ,du simpan , du contra , du rugi , wait trend consolidate n see reverse point
Genting MAV 200 is 4.39, why need to cut loss at 4.40? Genting already test the gap up on 24/11/23 yesterday, it may retest the MAV200 before real rebound. Forming double bottoms at 4.39 is great.
Many people wonder when can get the approval for Taurx Alzheimer medicine. For me the most important is whether the medicine is safety and effectiveness. The result show these two pint already. Try to think about it if you are an Alzheimer patient. What will you do if you know there is a drug which can delay deterioration of your condition or even reverse it if you at at very early stage? Is it worth to hold Taurx or Genting berhad due to accessibility
Escalation in Middle East - Israel carried out strikes on Iran, explosions were heard in the cities of Tehran, Isfahan, and Shiraz, as per local media reports.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
troy88
2,605 posts
Posted by troy88 > 3 weeks ago | Report Abuse
This genting seems like always jinx in this state..